rosiglitazone has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Bluher, M; Faber, R; Fasshauer, M; Köhler, U; Kralisch, S; Kratzsch, J; Lössner, U; Schubert, A; Sommer, G; Stangl, V; Stepan, H; Stumvoll, M; Vietzke, A | 1 |
2 other study(ies) available for rosiglitazone and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Secretory products from human adipocytes impair endothelial function via nuclear factor kappaB.
Topics: Adipocytes; Adipokines; Apoptosis; Cell Adhesion; Cells, Cultured; E-Selectin; Endothelium, Vascular; Female; Humans; Intercellular Adhesion Molecule-1; Leptin; Leupeptins; NF-kappa B; Resistin; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2008 |